$15.34
0.402.68%
Last update: Nov 4, 9:31 AM
Aktis Oncology Inc (AKTS) Stock Price, Quote, News & History
AKTSNASDAQ
You can purchase shares of Aktis Oncology (NASDAQ:AKTS) through any online brokerage.
Other companies in Aktis Oncology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Aktis Oncology has a consensus price target of $31.50.
The stock price for Aktis Oncology (NASDAQ: AKTS) is $15.34 last updated November 4, 2026 at 9:31 AM EST.
There are no upcoming dividends for Aktis Oncology.
Aktis Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Aktis Oncology.
Aktis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company...
